CytomX Therapeutics stock price
NASDAQ:CTMX · Nasdaq · Healthcare · sector #16CytomX Therapeutics's chart data is dated 2026-10-21. Recorded technical signals: RSI rebound, MACD bullish cross, Mean reversion. The display ticker is CTMX.
CytomX Therapeutics last closed at $2.40 (-4.38%) on 2026-10-21. Signals today: RSI rebound, MACD bullish cross, Mean reversion. Listed on Nasdaq. Trailing 12 months PER is -6.9×. Its overall grade ranks 480 of 726 stocks in Healthcare.
About this company
CytomX Therapeutics last closed at $2.40 (-4.38%) on 2026-10-21. Signals today: RSI rebound, MACD bullish cross, Mean reversion. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C+ · 480/726
Valuation grade B+
Related stocks
- Bristol Myers SquibbCustomer
- AstraZenecaCustomer
- AmgenCustomer
About CytomX Therapeutics
- What technical signals does CytomX Therapeutics (CTMX) have?
- CytomX Therapeutics current technical signals: RSI rebound, MACD bullish cross, Mean reversion.
- Is CytomX Therapeutics a cup-and-handle pattern?
- No. CytomX Therapeutics has no valid Cup signal right now.
- What published figures are available for CytomX Therapeutics?
- Market cap: $406.64M. Trailing 12 months PER: -6.9×. Latest quarter PBR: 1.82×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-21 dataset
Turn what you saw on this name into a strategy
Ask Q about CytomX Therapeutics, or open the plan table on the main site.
Ask Q about CytomX Therapeutics.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.